Immune-related myocarditis in two patients receiving camrelizumab therapy and document analysis

Zhang, C; Qin, S; Zuo, Z

Zuo, Z (通讯作者)，Chongqing Med Univ, Affiliated Hosp 1, Dept Cardiol, Youyi Rd, Chongqing 400016, Peoples R China.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022; 28 (6): 1350

Abstract

Introduction Camrelizumab is an antibody against programmed death protein 1 (PD-1) and is one of immune checkpoint inhibitors (ICI). ICI may lead to a......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索